AA amyloidosis as an adverse event of immune checkpoint inhibitor therapy: evidence from the FDA adverse event reporting system and a systematic review [0.03%]
免疫检查点抑制剂治疗的不良事件：美国食品药品监督管理局不良事件报告系统及系统综述的证据——淀粉样变性病_aa型
Umur Topcu,Buğra Han Esen,Sevval Nur Bektas et al.
Umur Topcu et al.
Background: Immune checkpoint inhibitors (ICIs) have transformed cancer therapy but are linked to immune-related adverse events (irAEs). Secondary (AA) amyloidosis, an inflammatory complication involving serum amyloid A d...
Cardiac Phenotype and Clinical Outcomes in Randall Disease versus Light-Chain Amyloidosis [0.03%]
Randall病与轻链淀粉样变性的心脏表型和临床结局比较
Martin Nicol,Camille Cohen,Alexis Talbot et al.
Martin Nicol et al.
Commentary to revisiting the genetic epidemiology of ATTRv in Spain: the Balearic Islands as a high-prevalence founder focus [0.03%]
ATTRv在西班牙的遗传流行病学重新评估述评：巴利阿里群岛作为一个高发祖先聚集点
Marta Domínguez-Martínez,Alfonso Caro-Llopis,Carmen Orellana
Marta Domínguez-Martínez
An Accelerated Sonication-Assisted Preparation method for mass spectrometry-based identification of subtype specific amyloidogenic proteins in fat aspirates [0.03%]
一种加速的基于声波振荡辅助制备方法，用于脂肪抽吸物中亚型特异性淀粉样蛋白组分的质谱鉴定
Nicolai Bjødstrup Palstrøm,Caroline Alqvist Lindegaard,Aleksandra Rojek et al.
Nicolai Bjødstrup Palstrøm et al.
Clinical profile and outcome of AA amyloidosis associated kidney disease in India [0.03%]
印度AA型淀粉样变性相关肾脏病的临床特征及转归
Bhavik Bansal,Akash Sarkar,Adarsh Barwad et al.
Bhavik Bansal et al.
Background: AA amyloidosis is a rare but significant cause of chronic kidney disease (CKD). We aimed to characterize the clinical profile of patients with AA amyloidosis affecting the kidneys in the Indian subcontinent. ...
Clinical and radiological stabilization following vutrisiran treatment in transthyretin leptomeningeal amyloidosis: a case report [0.03%]
特甲状腺素淀粉样变性脑膜病患者接受Vutrisiran治疗后的临床和放射学稳定：病例报告
Simone Rossi,Luca Spinardi,Pietro Guaraldi et al.
Simone Rossi et al.
Neuropathy impairment and nutritional status with eplontersen in patients with hereditary transthyretin-mediated amyloidosis [0.03%]
用于遗传性转甲状腺素蛋白介导的淀粉样变病患者的eplontersen对神经病变损害和营养状况的影响
Jonas Wixner,Isabel Conceição,John L Berk et al.
Jonas Wixner et al.
Cold pressor test and paradoxical blood pressure reduction in light chain amyloidosis [0.03%]
原纤维蛋白淀粉样变性冷冻压力试验及其血压反常降低现象
Raphael Patras,Georgios Georgiopoulos,Foteini Theodorakakou et al.
Raphael Patras et al.
Background: Patients with AL amyloidosis present sustained paradoxical vasodilation in response to sympathetic stimulation by cold pressor test (CPT). The clinical relevance is unknown. ...
Bile cast nephropathy presenting as acute kidney injury in systemic light chain amyloidosis with severe hepatic involvement [0.03%]
严重肝脏受累的全身轻链淀粉样变性患者出现急性肾损伤型胆汁铸形肾病
Rodolfo Garza-Morales,Liying Fu,Julie L Rosenthal et al.
Rodolfo Garza-Morales et al.
Revisiting the genetic epidemiology of ATTRv in Spain: the Balearic Islands as a high-prevalence founder focus [0.03%]
重访西班牙ATTRv的遗传流行病学：巴利阿里群岛作为一个高发原发焦点
Marc Ventayol-Guirado,Eugenia Cisneros-Barroso,Maria Antonia Ribot-Sansó et al.
Marc Ventayol-Guirado et al.